ATS 2017 ILD: Congress Highlights
This year, The American Thoracic Society (ATS) organised its 113th ATS-Conference in Washington, USA (19th - 24th May 2017) bringing together pulmonary experts from more than 90 countries. As in the previous years, the meeting presented a first-hand exchange on the latest scientific advances shaping the future of thoracic medicine.
The Congress programme covered the ground-breaking developments in the field of interstitial lung disease (ILD) and idiopathic pulmonary fibrosis (IPF). Renowned international pulmonary experts shared and discussed current research and the implications in improving care for patients.
Learn about the latest findings on interstitial lung diseases and idiopathic pulmonary fibrosis from ATS 2017:
Download the compact summaries of the ATS 2017 hot topics.
Find out what was discussed with regards to real world experience on anti-fibrotics in IPF!
Download the complete report from the product website!
Who should read the report?
- Pulmonologists who were not able to attend the ATS 2017 congress in person
- Clinicians from all over the world interested in new developments in IPF and ILD
- All other healthcare professionals interested in a comprehensive summary of the latest news from interstitial lung diseases and idiopathic pulmonary fibrosis